Bulk Manufacturer of Controlled Substances Application: Cayman Chemical Company, 95644-95647 [2016-31285]
Download as PDF
<![CDATA[
95644
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Controlled substance
Drug code
Carfentanil .......................................................................................................................................................................
Tapentadol .......................................................................................................................................................................
Fentanyl ...........................................................................................................................................................................
The company plans to manufacture
the above-listed controlled substances
in bulk for distribution to its customers.
In reference to drug codes 7360
marihuana and 7370
tetrahydrocannabinols the company
plans to bulk manufacture both as
synthetic substances. No other activity
for these drug codes is authorized for
this registration.
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
September 1, 2016, Cambridge Isotope
Laboratories, Inc., 50 Frontage Road,
Andover, Massachusetts 01810 applied
to be registered as a bulk manufacturer
of morphine (9300), a basic class of
controlled substance listed in schedule
II:
The company plans to utilize small
quantities of the listed controlled
substance for use in product
development of analytical reference
standards, for distribution to its
customers.
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–31279 Filed 12–27–16; 8:45 am]
BILLING CODE 4410–09–P
[FR Doc. 2016–31271 Filed 12–27–16; 8:45 am]
DEPARTMENT OF JUSTICE
BILLING CODE 4410–09–P
[Docket No. DEA–392]
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Cambridge
Isotope Laboratories
ACTION:
[Docket No. DEA–392]
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
DATES:
sradovich on DSK3GMQ082PROD with NOTICES
Drug Enforcement Administration
VerDate Sep<11>2014
18:54 Dec 27, 2016
Jkt 241001
Importer of Controlled Substances
Application: Wildlife Laboratories, Inc.
ACTION:
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.34(a) on
or before January 27, 2017. Such
persons may also file a written request
for a hearing on the application
pursuant to 21 CFR 1301.43 on or before
January 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for hearing must be
sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152. All requests for hearing
should also be sent to: (1) Drug
Enforcement Administration, Attn:
Hearing Clerk/LJ, 8701 Morrissette
Drive, Springfield, Virginia 22152; and
(2) Drug Enforcement Administration,
Attn: DEA Federal Register
Representative/DRW, 8701 Morrissette
Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The
Attorney General has delegated her
PO 00000
Frm 00090
Fmt 4703
Sfmt 4703
II
II
II
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.34(a), this is notice that on
September 20, 2016, Wildlife
Laboratories, Inc., 1230 W. Ash Street,
Suite D, Windsor, Colorado 80550–8055
applied to be registered as an importer
of the following basic class of controlled
substances.
Controlled substance
Notice of application.
DATES:
9743
9780
9801
Schedule
Thiafentanil ...............
Drug
code
9729
Schedule
II
The company plans to import the
listed controlled substance for sale to its
customers.
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–31272 Filed 12–27–16; 8:45 am]
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–392]
Bulk Manufacturer of Controlled
Substances Application: Cayman
Chemical Company
ACTION:
Notice of application.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
ADDRESSES: Written comments should
be sent to: Drug Enforcement
DATES:
E:\FR\FM\28DEN1.SGM
28DEN1
95645
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
SUPPLEMENTARY INFORMATION:
exercise all necessary functions with
respect to the promulgation and
implementation of 21 CFR part 1301,
incident to the registration of
manufacturers, distributors, dispensers,
importers, and exporters of controlled
substances (other than final orders in
connection with suspension, denial, or
revocation of registration) has been
redelegated to the Assistant
Administrator of the DEA Diversion
Control Division (‘‘Assistant
Administrator’’) pursuant to section 7 of
28 CFR part 0, appendix to subpart R.
In accordance with 21 CFR
1301.33(a), this is notice that on August
16, 2016, Cayman Chemical Company,
1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered
as a bulk manufacturer of the following
basic classes of controlled substances:
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
3-Fluoro-N-methylcathinone (3–FMC) .....................................................................................................................
Cathinone .................................................................................................................................................................
Methcathinone .........................................................................................................................................................
4-Fluoro-N-methylcathinone (4–FMC) .....................................................................................................................
Pentedrone (a-methylaminovalerophenone) ...........................................................................................................
Mephedrone (4-Methyl-N-methylcathinone) ............................................................................................................
4-Methyl-N-ethylcathinone (4–MEC) .......................................................................................................................
Naphyrone ...............................................................................................................................................................
N-Ethylamphetamine ...............................................................................................................................................
N,N-Dimethylamphetamine ......................................................................................................................................
Fenethylline ..............................................................................................................................................................
Aminorex ..................................................................................................................................................................
4-Methylaminorex (cis isomer) ................................................................................................................................
Gamma Hydroxybutyric Acid ...................................................................................................................................
Methaqualone ..........................................................................................................................................................
Mecloqualone ...........................................................................................................................................................
JWH–250 (1-Pentyl-3-(2-methoxyphenylacetyl) indole) ..........................................................................................
SR–18 (Also known as RCS–8) (1-Cyclohexylethyl-3-(2-methoxyphenylacetyl) indole) ........................................
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro-pentyl)1H-indol-3-yl](2,2,3,3-tetramethylcyclopropyl)methanone .........
AB–FUBINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-indazole-3-carboxamide) .............
JWH–019 (1-Hexyl-3-(1-naphthoyl)indole) ..............................................................................................................
AB–PINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole- ..........................................................
3-carboxamide) ........................................................................................................................................................
THJ–2201 [1-(5-fluoropentyl)-1H-indazol-3- ............................................................................................................
yl](naphthalen-1-yl)methanone ................................................................................................................................
AB–CHMINACA (N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- .....................................................
1H-indazole-3-carboxamide .....................................................................................................................................
MAB–CHMINACA (N-(1-amino-3,3dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide)
ADB–PINACA (N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-pentyl-1H-indazole-3-carboxamide) .........................
APINACA and AKB48 N-(1-Adamantyl)-1-pentyl-1H-indazole-3-carboxamide .......................................................
JWH–081 (1-Pentyl-3-(1-(4-methoxynaphthoyl) indole) ..........................................................................................
SR–19 (Also known as RCS–4) (1-Pentyl-3-[(4-methoxy)-benzoyl] indole ............................................................
JWH–018 (also known as AM678) (1-Pentyl-3-(1-naphthoyl)indole) ......................................................................
JWH–122 (1-Pentyl-3-(4-methyl-1-naphthoyl) indole) .............................................................................................
UR–144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3-tetramethylcyclopropyl)methanone .........................................................
JWH–073 (1-Butyl-3-(1-naphthoyl)indole) ...............................................................................................................
JWH–200 (1-[2-(4-Morpholinyl)ethyl]-3-(1-naphthoyl)indole) ..................................................................................
AM2201 (1-(5-Fluoropentyl)-3-(1-naphthoyl) indole) ...............................................................................................
JWH–203 (1-Pentyl-3-(2-chlorophenylacetyl) indole) ..............................................................................................
PB–22 (Quinolin-8-yl 1-pentyl-1H-indole-3-carboxylate) .........................................................................................
5F–PB–22 (Quinolin-8-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate) ....................................................................
Alpha-ethyltryptamine ..............................................................................................................................................
Ibogaine ...................................................................................................................................................................
CP–47,497 (5-(1,1-Dimethylheptyl)-2-[(1R,3S)-3-hydroxycyclohexyl-phenol) .........................................................
CP–47,497 C8 Homologue (5-(1,1-Dimethyloctyl)-2-[(1R,3S)3-hydroxycyclohexyl-phenol) ...................................
Lysergic acid diethylamide ......................................................................................................................................
2,5-Dimethoxy-4-(n)-propylthiophenethylamine (2C–T–7) ......................................................................................
Marihuana ................................................................................................................................................................
Tetrahydrocannabinols ............................................................................................................................................
Mescaline .................................................................................................................................................................
2-(4-Ethylthio-2,5-dimethoxyphenyl) ethanamine (2C–T–2 ) ..................................................................................
3,4,5-Trimethoxyamphetamine ................................................................................................................................
4-Bromo-2,5-dimethoxyamphetamine ......................................................................................................................
4-Bromo-2,5-dimethoxyphenethylamine ..................................................................................................................
4-Methyl-2,5-dimethoxyamphetamine ......................................................................................................................
2,5-Dimethoxyamphetamine ....................................................................................................................................
JWH–398 (1-Pentyl-3-(4-chloro-1-naphthoyl) indole) ..............................................................................................
2,5-Dimethoxy-4-ethylamphetamine ........................................................................................................................
3,4-Methylenedioxyamphetamine ............................................................................................................................
5-Methoxy-3,4-methylenedioxyamphetamine ..........................................................................................................
N-Hydroxy-3,4-methylenedioxyamphetamine ..........................................................................................................
VerDate Sep<11>2014
18:54 Dec 27, 2016
Jkt 241001
PO 00000
Frm 00091
Fmt 4703
Sfmt 4703
E:\FR\FM\28DEN1.SGM
28DEN1
Schedule
1233
1235
1237
1238
1246
1248
1249
1258
1475
1480
1503
1585
1590
2010
2565
2572
6250
7008
7011
7012
7019
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
7023
I.
7024
I.
7031
7032
7035
7048
7081
7104
7118
7122
7144
7173
7200
7201
7203
7222
7225
7249
7260
7297
7298
7315
7348
7360
7370
7381
7385
7390
7391
7392
7395
7396
7398
7399
7400
7401
7402
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
95646
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
sradovich on DSK3GMQ082PROD with NOTICES
Controlled substance
Drug code
3,4-Methylenedioxy-N-ethylamphetamine ...............................................................................................................
3,4-Methylenedioxymethamphetamine ....................................................................................................................
4-Methoxyamphetamine ..........................................................................................................................................
5-Methoxy-N–N-dimethyltryptamine ........................................................................................................................
Alpha-methyltryptamine ...........................................................................................................................................
Bufotenine ................................................................................................................................................................
Diethyltryptamine .....................................................................................................................................................
Dimethyltryptamine ..................................................................................................................................................
Psilocybin .................................................................................................................................................................
Psilocyn ....................................................................................................................................................................
5-Methoxy-N,N-diisopropyltryptamine ......................................................................................................................
N-Benzylpiperazine ..................................................................................................................................................
2-(2,5-Dimethoxy-4-methylphenyl) ethanamine (2C–D) ..........................................................................................
2-(2,5-Dimethoxy-4-ethylphenyl) ethanamine (2C–E ) ............................................................................................
2-(2,5-Dimethoxyphenyl) ethanamine (2C–H) .........................................................................................................
2-(4-Iodo-2,5-dimethoxyphenyl) ethanamine (2C–I) ................................................................................................
2-(4-Chloro-2,5-dimethoxyphenyl) ethanamine (2C–C) ..........................................................................................
2-(2,5-Dimethoxy-4-nitro-phenyl) ethanamine (2C–N) ............................................................................................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) ethanamine (2C–P) .....................................................................................
2-(4-Isopropylthio)-2,5-dimethoxyphenyl) ethanamine (2C–T–4 ) ...........................................................................
MDPV (3,4-Methylenedioxypyrovalerone) ...............................................................................................................
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25B–NBOMe) ............................................
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25C–NBOMe) ............................................
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2-methoxybenzyl) ethanamine (25I–NBOMe) .................................................
Methylone (3,4-Methylenedioxy-N-methylcathinone) ..............................................................................................
Butylone ...................................................................................................................................................................
Pentylone .................................................................................................................................................................
alpha-pyrrolidinopentiophenone (a-PVP) ................................................................................................................
alpha-pyrrolidinobutiophenone (a-PBP) ..................................................................................................................
AM–694 (1-(5-Fluoropentyl)-3-(2-iodobenzoyl) indole) ...........................................................................................
Acetyldihydrocodeine ...............................................................................................................................................
Benzylmorphine .......................................................................................................................................................
Codeine-N-oxide ......................................................................................................................................................
Desomorphine ..........................................................................................................................................................
Etorphine (except HCl) ............................................................................................................................................
Codeine methylbromide ...........................................................................................................................................
Dihydromorphine ......................................................................................................................................................
Heroin ......................................................................................................................................................................
Morphine-N-oxide ....................................................................................................................................................
Normorphine ............................................................................................................................................................
Tilidine ......................................................................................................................................................................
Para-Fluorofentanyl .................................................................................................................................................
3-Methylfentanyl .......................................................................................................................................................
Alpha-methylfentanyl ...............................................................................................................................................
Acetyl-alpha-methylfentanyl .....................................................................................................................................
Acetyl Fentanyl (N-(1-phenethylpiperidin-4-yl)-N-phenylacetamide) .......................................................................
Butyryl Fentanyl .......................................................................................................................................................
Beta-hydroxyfentanyl ...............................................................................................................................................
Beta-hydroxy-3-methylfentanyl ................................................................................................................................
3-Methylthiofentanyl .................................................................................................................................................
Thiofentanyl .............................................................................................................................................................
Beta-hydroxythiofentanyl .........................................................................................................................................
Amphetamine ...........................................................................................................................................................
Methamphetamine ...................................................................................................................................................
Lisdexamfetamine ....................................................................................................................................................
Phenmetrazine .........................................................................................................................................................
Methylphenidate .......................................................................................................................................................
Amobarbital ..............................................................................................................................................................
Pentobarbital ............................................................................................................................................................
Secobarbital .............................................................................................................................................................
Phencyclidine ...........................................................................................................................................................
Phenylacetone .........................................................................................................................................................
Cocaine ....................................................................................................................................................................
Codeine ....................................................................................................................................................................
Etorphine HCl ..........................................................................................................................................................
Dihydrocodeine ........................................................................................................................................................
Oxycodone ...............................................................................................................................................................
Hydromorphone .......................................................................................................................................................
Ecgonine ..................................................................................................................................................................
Ethylmorphine ..........................................................................................................................................................
Hydrocodone ............................................................................................................................................................
Levomethorphan ......................................................................................................................................................
Levorphanol .............................................................................................................................................................
Isomethadone ..........................................................................................................................................................
VerDate Sep<11>2014
18:54 Dec 27, 2016
Jkt 241001
PO 00000
Frm 00092
Fmt 4703
Sfmt 4703
E:\FR\FM\28DEN1.SGM
28DEN1
7404
7405
7411
7431
7432
7433
7434
7435
7437
7438
7439
7493
7508
7509
7517
7518
7519
7521
7524
7532
7535
7536
7537
7538
7540
7541
7542
7545
7546
7694
9051
9052
9053
9055
9056
9070
9145
9200
9307
9313
9750
9812
9813
9814
9815
9821
9822
9830
9831
9833
9835
9836
1100
1105
1205
1631
1724
2125
2270
2315
7471
8501
9041
9050
9059
9120
9143
9150
9180
9190
9193
9210
9220
9226
Schedule
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
I.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
95647
Federal Register / Vol. 81, No. 249 / Wednesday, December 28, 2016 / Notices
Controlled substance
Drug code
Meperidine ...............................................................................................................................................................
Meperidine intermediate-B .......................................................................................................................................
Methadone ...............................................................................................................................................................
Dextropropoxyphene, bulk (non-dosage forms) ......................................................................................................
Morphine ..................................................................................................................................................................
Thebaine ..................................................................................................................................................................
Oxymorphone ..........................................................................................................................................................
Alfentanil ..................................................................................................................................................................
Remifentanil .............................................................................................................................................................
Sufentanil .................................................................................................................................................................
Carfentanil ................................................................................................................................................................
Tapentadol ...............................................................................................................................................................
Fentanyl ...................................................................................................................................................................
The company plans to manufacture
bulk controlled substances for use in
product development of analytical
reference standards, for distribution to
its customers.
Drug Enforcement Administration
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
ACTION:
[FR Doc. 2016–31285 Filed 12–27–16; 8:45 am]
Notice of registration.
Registrants listed below have
applied for and been granted
registration by the Drug Enforcement
SUMMARY:
BILLING CODE 4410–09–P
Company
sradovich on DSK3GMQ082PROD with NOTICES
Rhodes Technologies ...........................................................
Bellwyck Clinical Services ....................................................
Cerilliant Corporation ............................................................
Noramco, Inc ........................................................................
Cody Laboratories, Inc .........................................................
AMRI Rensselaer, Inc ..........................................................
ALMAC Clinical Services Incorp (ACSI) ..............................
Fresenius Kabi USA, LLC ....................................................
Akorn, Inc .............................................................................
Actavis Laboratories FL, Inc ................................................
Unither Manufacturing LLC ..................................................
Cambrex Charles City ..........................................................
United States Pharmacopeial Convention ...........................
R & D Systems, Inc ..............................................................
Catalent CTS, LLC ...............................................................
VerDate Sep<11>2014
18:54 Dec 27, 2016
Jkt 241001
The companies listed below applied
to be registered as importers of various
basic classes of controlled substances.
Information on previously published
notices is listed in the table below. No
comments or objections were submitted
and no requests for hearing were
submitted for these notices.
FR docket
The DEA has considered the factors in
21 U.S.C. 823, 952(a) and 958(a) and
determined that the registration of the
listed registrants to import the
applicable basic classes of schedule I or
II controlled substances is consistent
with the public interest and with United
States obligations under international
treaties, conventions, or protocols in
effect on May 1, 1971. The DEA
investigated each company’s
maintenance of effective controls
against diversion by inspecting and
testing each company’s physical
security systems, verifying each
company’s compliance with state and
local laws, and reviewing each
company’s background and history.
Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance
with 21 CFR 1301.34, the DEA has
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
II.
Administration (DEA) as importers of
various classes of schedule I or II
controlled substances.
DEPARTMENT OF JUSTICE
Importer of Controlled Substances
Registration
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
9230
9233
9250
9273
9300
9333
9652
9737
9739
9740
9743
9780
9801
Schedule
81
81
81
81
81
81
81
81
81
81
81
81
81
81
81
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
FR
46956
54603
57933
57932
54602
54603
54602
54601
57935
54602
61250
63222
63220
64509
66081
Published
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
........................................................................
granted a registration as an importer for
schedule I or II controlled substances to
the above listed persons.
Dated: December 19, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016–31273 Filed 12–27–16; 8:45 am]
July 19, 2016.
August 16, 2016.
August 24, 2016.
August 24, 2016.
August 16, 2016.
August 16, 2016.
August 16, 2016.
August 16, 2016.
August 24, 2016.
August 16, 2016.
September 6, 2016.
September 14, 2016.
September 14, 2016.
September 20, 2016.
September 26, 2016.
Registered bulk manufacturers of
the affected basic classes, and
applicants therefore, may file written
comments on or objections to the
issuance of the proposed registration in
accordance with 21 CFR 1301.33(a) on
or before February 27, 2017.
DATES:
Drug Enforcement Administration
Written comments should
be sent to: Drug Enforcement
Administration, Attention: DEA Federal
Register Representative/DRW, 8701
Morrissette Drive, Springfield, Virginia
22152.
[Docket No. DEA–392]
SUPPLEMENTARY INFORMATION:
ADDRESSES:
BILLING CODE 4410–09–P
DEPARTMENT OF JUSTICE
Bulk Manufacturer of Controlled
Substances Application: Johnson
Matthey Inc.
ACTION:
PO 00000
Notice of application.
Frm 00093
Fmt 4703
Sfmt 4703
The
Attorney General has delegated her
authority under the Controlled
Substances Act to the Administrator of
the Drug Enforcement Administration
(DEA), 28 CFR 0.100(b). Authority to
exercise all necessary functions with
E:\FR\FM\28DEN1.SGM
28DEN1
]]>Agencies
[Federal Register Volume 81, Number 249 (Wednesday, December 28, 2016)]
[Notices]
[Pages 95644-95647]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-31285]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-392]
Bulk Manufacturer of Controlled Substances Application: Cayman
Chemical Company
ACTION: Notice of application.
-----------------------------------------------------------------------
DATES: Registered bulk manufacturers of the affected basic classes, and
applicants therefore, may file written comments on or objections to the
issuance of the proposed registration in accordance with 21 CFR
1301.33(a) on or before February 27, 2017.
ADDRESSES: Written comments should be sent to: Drug Enforcement
[[Page 95645]]
Administration, Attention: DEA Federal Register Representative/DRW,
8701 Morrissette Drive, Springfield, Virginia 22152.
SUPPLEMENTARY INFORMATION: The Attorney General has delegated her
authority under the Controlled Substances Act to the Administrator of
the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority
to exercise all necessary functions with respect to the promulgation
and implementation of 21 CFR part 1301, incident to the registration of
manufacturers, distributors, dispensers, importers, and exporters of
controlled substances (other than final orders in connection with
suspension, denial, or revocation of registration) has been redelegated
to the Assistant Administrator of the DEA Diversion Control Division
(``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0,
appendix to subpart R.
In accordance with 21 CFR 1301.33(a), this is notice that on August
16, 2016, Cayman Chemical Company, 1180 East Ellsworth Road, Ann Arbor,
Michigan 48108 applied to be registered as a bulk manufacturer of the
following basic classes of controlled substances:
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
3-Fluoro-N-methylcathinone (3-FMC)..... 1233 I
Cathinone.............................. 1235 I
Methcathinone.......................... 1237 I
4-Fluoro-N-methylcathinone (4-FMC)..... 1238 I
Pentedrone ([alpha]- 1246 I
methylaminovalerophenone).............
Mephedrone (4-Methyl-N-methylcathinone) 1248 I
4-Methyl-N-ethylcathinone (4-MEC)...... 1249 I
Naphyrone.............................. 1258 I
N-Ethylamphetamine..................... 1475 I
N,N-Dimethylamphetamine................ 1480 I
Fenethylline........................... 1503 I
Aminorex............................... 1585 I
4-Methylaminorex (cis isomer).......... 1590 I
Gamma Hydroxybutyric Acid.............. 2010 I
Methaqualone........................... 2565 I
Mecloqualone........................... 2572 I
JWH-250 (1-Pentyl-3-(2- 6250 I
methoxyphenylacetyl) indole)..........
SR-18 (Also known as RCS-8) (1- 7008 I
Cyclohexylethyl-3-(2-
methoxyphenylacetyl) indole)..........
5-Flouro-UR-144 and XLR11 [1-(5-Fluoro- 7011 I
pentyl)1H-indol-3-yl](2,2,3,3-
tetramethylcyclopropyl)methanone......
AB-FUBINACA (N-(1-amino-3-methyl-1- 7012 I
oxobutan-2-yl)-1-(4-fluorobenzyl)-1H-
indazole-3-carboxamide)...............
JWH-019 (1-Hexyl-3-(1-naphthoyl)indole) 7019 I
AB-PINACA (N-(1-amino-3-methyl-1- 7023 I
oxobutan-2-yl)-1-pentyl-1H-indazole-..
3-carboxamide).........................
THJ-2201 [1-(5-fluoropentyl)-1H-indazol- 7024 I
3-....................................
yl](naphthalen-1-yl)methanone..........
AB-CHMINACA (N-(1-amino-3-methyl-1- 7031 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-..
1H-indazole-3-carboxamide..............
MAB-CHMINACA (N-(1-amino-3,3dimethyl-1- 7032 I
oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-
indazole-3-carboxamide)...............
ADB-PINACA (N-(1-amino-3,3-dimethyl-1- 7035 I
oxobutan-2-yl)-1-pentyl-1H-indazole-3-
carboxamide)..........................
APINACA and AKB48 N-(1-Adamantyl)-1- 7048 I
pentyl-1H-indazole-3-carboxamide......
JWH-081 (1-Pentyl-3-(1-(4- 7081 I
methoxynaphthoyl) indole).............
SR-19 (Also known as RCS-4) (1-Pentyl-3- 7104 I
[(4-methoxy)-benzoyl] indole..........
JWH-018 (also known as AM678) (1-Pentyl- 7118 I
3-(1-naphthoyl)indole)................
JWH-122 (1-Pentyl-3-(4-methyl-1- 7122 I
naphthoyl) indole)....................
UR-144 (1-Pentyl-1H-indol-3-yl)(2,2,3,3- 7144 I
tetramethylcyclopropyl)methanone......
JWH-073 (1-Butyl-3-(1-naphthoyl)indole) 7173 I
JWH-200 (1-[2-(4-Morpholinyl)ethyl]-3- 7200 I
(1-naphthoyl)indole)..................
AM2201 (1-(5-Fluoropentyl)-3-(1- 7201 I
naphthoyl) indole)....................
JWH-203 (1-Pentyl-3-(2- 7203 I
chlorophenylacetyl) indole)...........
PB-22 (Quinolin-8-yl 1-pentyl-1H-indole- 7222 I
3-carboxylate)........................
5F-PB-22 (Quinolin-8-yl 1-(5- 7225 I
fluoropentyl)-1H-indole-3-carboxylate)
Alpha-ethyltryptamine.................. 7249 I
Ibogaine............................... 7260 I
CP-47,497 (5-(1,1-Dimethylheptyl)-2- 7297 I
[(1R,3S)-3-hydroxycyclohexyl-phenol)..
CP-47,497 C8 Homologue (5-(1,1- 7298 I
Dimethyloctyl)-2-[(1R,3S)3-
hydroxycyclohexyl-phenol).............
Lysergic acid diethylamide............. 7315 I
2,5-Dimethoxy-4-(n)- 7348 I
propylthiophenethylamine (2C-T-7).....
Marihuana.............................. 7360 I
Tetrahydrocannabinols.................. 7370 I
Mescaline.............................. 7381 I
2-(4-Ethylthio-2,5-dimethoxyphenyl) 7385 I
ethanamine (2C-T-2 )..................
3,4,5-Trimethoxyamphetamine............ 7390 I
4-Bromo-2,5-dimethoxyamphetamine....... 7391 I
4-Bromo-2,5-dimethoxyphenethylamine.... 7392 I
4-Methyl-2,5-dimethoxyamphetamine...... 7395 I
2,5-Dimethoxyamphetamine............... 7396 I
JWH-398 (1-Pentyl-3-(4-chloro-1- 7398 I
naphthoyl) indole)....................
2,5-Dimethoxy-4-ethylamphetamine....... 7399 I
3,4-Methylenedioxyamphetamine.......... 7400 I
5-Methoxy-3,4-methylenedioxyamphetamine 7401 I
N-Hydroxy-3,4-methylenedioxyamphetamine 7402 I
[[Page 95646]]
3,4-Methylenedioxy-N-ethylamphetamine.. 7404 I
3,4-Methylenedioxymethamphetamine...... 7405 I
4-Methoxyamphetamine................... 7411 I
5-Methoxy-N-N-dimethyltryptamine....... 7431 I
Alpha-methyltryptamine................. 7432 I
Bufotenine............................. 7433 I
Diethyltryptamine...................... 7434 I
Dimethyltryptamine..................... 7435 I
Psilocybin............................. 7437 I
Psilocyn............................... 7438 I
5-Methoxy-N,N-diisopropyltryptamine.... 7439 I
N-Benzylpiperazine..................... 7493 I
2-(2,5-Dimethoxy-4-methylphenyl) 7508 I
ethanamine (2C-D).....................
2-(2,5-Dimethoxy-4-ethylphenyl) 7509 I
ethanamine (2C-E )....................
2-(2,5-Dimethoxyphenyl) ethanamine (2C- 7517 I
H)....................................
2-(4-Iodo-2,5-dimethoxyphenyl) 7518 I
ethanamine (2C-I).....................
2-(4-Chloro-2,5-dimethoxyphenyl) 7519 I
ethanamine (2C-C).....................
2-(2,5-Dimethoxy-4-nitro-phenyl) 7521 I
ethanamine (2C-N).....................
2-(2,5-Dimethoxy-4-(n)-propylphenyl) 7524 I
ethanamine (2C-P).....................
2-(4-Isopropylthio)-2,5- 7532 I
dimethoxyphenyl) ethanamine (2C-T-4 ).
MDPV (3,4-Methylenedioxypyrovalerone).. 7535 I
2-(4-bromo-2,5-dimethoxyphenyl)-N-(2- 7536 I
methoxybenzyl) ethanamine (25B-NBOMe).
2-(4-chloro-2,5-dimethoxyphenyl)-N-(2- 7537 I
methoxybenzyl) ethanamine (25C-NBOMe).
2-(4-iodo-2,5-dimethoxyphenyl)-N-(2- 7538 I
methoxybenzyl) ethanamine (25I-NBOMe).
Methylone (3,4-Methylenedioxy-N- 7540 I
methylcathinone)......................
Butylone............................... 7541 I
Pentylone.............................. 7542 I
alpha-pyrrolidinopentiophenone ([alpha]- 7545 I
PVP)..................................
alpha-pyrrolidinobutiophenone ([alpha]- 7546 I
PBP)..................................
AM-694 (1-(5-Fluoropentyl)-3-(2- 7694 I
iodobenzoyl) indole)..................
Acetyldihydrocodeine................... 9051 I
Benzylmorphine......................... 9052 I
Codeine-N-oxide........................ 9053 I
Desomorphine........................... 9055 I
Etorphine (except HCl)................. 9056 I
Codeine methylbromide.................. 9070 I
Dihydromorphine........................ 9145 I
Heroin................................. 9200 I
Morphine-N-oxide....................... 9307 I
Normorphine............................ 9313 I
Tilidine............................... 9750 I
Para-Fluorofentanyl.................... 9812 I
3-Methylfentanyl....................... 9813 I
Alpha-methylfentanyl................... 9814 I
Acetyl-alpha-methylfentanyl............ 9815 I
Acetyl Fentanyl (N-(1- 9821 I
phenethylpiperidin-4-yl)-N-
phenylacetamide)......................
Butyryl Fentanyl....................... 9822 I
Beta-hydroxyfentanyl................... 9830 I
Beta-hydroxy-3-methylfentanyl.......... 9831 I
3-Methylthiofentanyl................... 9833 I
Thiofentanyl........................... 9835 I
Beta-hydroxythiofentanyl............... 9836 I
Amphetamine............................ 1100 II
Methamphetamine........................ 1105 II
Lisdexamfetamine....................... 1205 II
Phenmetrazine.......................... 1631 II
Methylphenidate........................ 1724 II
Amobarbital............................ 2125 II
Pentobarbital.......................... 2270 II
Secobarbital........................... 2315 II
Phencyclidine.......................... 7471 II
Phenylacetone.......................... 8501 II
Cocaine................................ 9041 II
Codeine................................ 9050 II
Etorphine HCl.......................... 9059 II
Dihydrocodeine......................... 9120 II
Oxycodone.............................. 9143 II
Hydromorphone.......................... 9150 II
Ecgonine............................... 9180 II
Ethylmorphine.......................... 9190 II
Hydrocodone............................ 9193 II
Levomethorphan......................... 9210 II
Levorphanol............................ 9220 II
Isomethadone........................... 9226 II
[[Page 95647]]
Meperidine............................. 9230 II
Meperidine intermediate-B.............. 9233 II
Methadone.............................. 9250 II
Dextropropoxyphene, bulk (non-dosage 9273 II
forms)................................
Morphine............................... 9300 II
Thebaine............................... 9333 II
Oxymorphone............................ 9652 II
Alfentanil............................. 9737 II
Remifentanil........................... 9739 II
Sufentanil............................. 9740 II
Carfentanil............................ 9743 II
Tapentadol............................. 9780 II
Fentanyl............................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture bulk controlled substances for use
in product development of analytical reference standards, for
distribution to its customers.
Dated: December 20, 2016.
Louis J. Milione,
Assistant Administrator.
[FR Doc. 2016-31285 Filed 12-27-16; 8:45 am]
BILLING CODE 4410-09-P
